A Pilot Study of Digital Cognitive Behavioral Therapy for Veterans



Status:Not yet recruiting
Conditions:Insomnia Sleep Studies
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:9/30/2018
Start Date:September 2018
End Date:January 2020
Contact:Shannon McCaslin-Rodrigo, Ph.D.
Email:Shannon.McCaslin@va.gov
Phone:650/493-5000

Use our guide to learn which trials are right for you!

A Pilot Study of Digital Cognitive Behavioral Therapy for Veterans With Insomnia and Comorbid Psychopathology

The proposed study is a multiple baseline design pilot study which seeks to evaluate the
impact of digitally administered CBT-I, using the Sleepio platform, for the treatment of
insomnia disorder among Veterans with co-morbid psychopathology. In addition, information
related to acceptability and feasibility of the intervention among a Veteran sample will be
obtained.

Cognitive Behavioral Therapy for Insomnia (CBT-I) is considered the front-line intervention
for individuals with insomnia and has recently been rolled-out throughout the Veterans Health
Administration (VHA; Manber et al., 2012). CBT-I includes behavioral (sleep restriction,
stimulus control, relaxation exercises), cognitive (cognitive restructuring, mindfulness
exercise), and psychoeducation (sleep hygiene) components. While CBT-I has been demonstrated
to be a highly efficacious and effective intervention, it is a specialized intervention that
can be costly and is in limited supply based on the level of training required and number of
providers available. For this reason, digital administration of CBT-I has been examined and
research has demonstrated initial efficacy among community samples (Ritterband et al., 2009;
Vincent et al., 2009; Espie et al., 2012), with one platform, Sleepio, demonstrating efficacy
compared to a placebo intervention (Espie et al., 2012; Espie et al., 2014). For this reason,
the current study will utilize the Sleepio platform which provides an interactive, customized
and tailored delivery of CBT-I.

Inclusion Criteria:

Participants must be:

- at least 18 years of age (no upper age limit)

- meet DSM-5 defined criteria for insomnia disorder

- be on a stable dose of any prescription medication (including sleep medication) for at
least 2 weeks prior to the in-person screening assessment

- have comorbid psychopathology (i.e., symptoms of Posttraumatic Stress Disorder (PTSD),
anxiety, and/or depression)

Exclusion Criteria:

- limited mental competency (not oriented to person, place, or time) and the inability
to give informed, voluntary, or written consent to participate

- high risk for sleep apnea (STOP-Bang score >/= 3)

- current bipolar disorder

- current or lifetime psychotic disorders

- seizure disorders

- active suicidal ideation
We found this trial at
1
site
3801 Miranda Avenue
Palo Alto, California 94304
650-493-5000
VA Palo Alto Health Care System The VA Palo Alto Health Care System (VAPAHCS) consists...
327
mi
from 91732
Palo Alto, CA
Click here to add this to my saved trials